HBAN vs MTB

HBAN presents a mixed profile with a stable Piotroski F-Score of 4/9 and a Graham Number of $20.76 suggesting significant defensive undervaluation relative to its current price of $16.38. While the bank maintains a healthy dividend payout ratio and consistent historical earnings beats, there is a concerning divergence between revenue growth (+10.30%) and earnings growth (-10.90%). The technical trend is currently bearish (0/100), and the intrinsic growth-based value ($9.73) suggests the market is pricing in premiums that the current earnings trajectory does not fully support.

MTB presents a stark contrast between deep value and deteriorating fundamental health, highlighted by a weak Piotroski F-Score of 2/9. While the stock trades significantly below its Graham Number ($263.85) and Intrinsic Value ($525.1), the low health score and bearish insider sentiment suggest underlying operational risks. Strong YoY earnings growth of 24.4% and a sustainable dividend payout provide a floor, but the technical trend and insider selling indicate a lack of immediate conviction. The overall outlook is neutral as the valuation discount is offset by fundamental health concerns.